158 related articles for article (PubMed ID: 2858983)
1. Informed consent as a form of volunteer bias.
Edlund MJ; Craig TJ; Richardson MA
Am J Psychiatry; 1985 May; 142(5):624-7. PubMed ID: 2858983
[TBL] [Abstract][Full Text] [Related]
2. Informed consent and tardive dyskinesia.
Kleinman I; Schachter D; Koritar E
Am J Psychiatry; 1989 Jul; 146(7):902-4. PubMed ID: 2568093
[TBL] [Abstract][Full Text] [Related]
3. Informed consent for neuroleptic therapy.
Deveaugh-Geiss J
Am J Psychiatry; 1979 Jul; 136(7):959-62. PubMed ID: 36766
[TBL] [Abstract][Full Text] [Related]
4. Missing the boat: competence and consent in psychiatric research.
Appelbaum PS
Am J Psychiatry; 1998 Nov; 155(11):1486-8. PubMed ID: 9812106
[No Abstract] [Full Text] [Related]
5. Problems of long-term informed consent.
Jaffe R
Bull Am Acad Psychiatry Law; 1986; 14(2):163-9. PubMed ID: 2873852
[TBL] [Abstract][Full Text] [Related]
6. Current status of institutionalized mental health patients' right to refuse psychotropic drugs.
Kemna DJ
J Leg Med; 1985 Mar; 6(1):107-38. PubMed ID: 2860193
[No Abstract] [Full Text] [Related]
7. Tardive dyskinesia and informed consent: myths and realities.
Munetz MR; Roth LH; Cornes CL
Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012
[No Abstract] [Full Text] [Related]
8. Informed consent and tardive dyskinesia.
Wettstein RM
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):65S-70S. PubMed ID: 3065366
[TBL] [Abstract][Full Text] [Related]
9. The rationale and ethics of medication-free research in schizophrenia.
Carpenter WT; Schooler NR; Kane JM
Arch Gen Psychiatry; 1997 May; 54(5):401-7. PubMed ID: 9152092
[TBL] [Abstract][Full Text] [Related]
10. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
Schachter DC; Kleinman I
Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
[TBL] [Abstract][Full Text] [Related]
11. Enhancing informed consent for research and treatment.
Dunn LB; Jeste DV
Neuropsychopharmacology; 2001 Jun; 24(6):595-607. PubMed ID: 11331139
[TBL] [Abstract][Full Text] [Related]
12. Responsibility and compensation for tardive dyskinesia.
Appelbaum PS; Schaffner K; Meisel A
Am J Psychiatry; 1985 Jul; 142(7):806-10. PubMed ID: 2861753
[TBL] [Abstract][Full Text] [Related]
13. Liberty and tardive dyskinesia: informed consent to antipsychotic medication in the forensic psychiatric hospital.
Kleinman SB
J Forensic Sci; 1990 Sep; 35(5):1155-62. PubMed ID: 2230691
[TBL] [Abstract][Full Text] [Related]
14. The effect of psychopathology on the ability of schizophrenic patients to give informed consent.
Schachter D; Kleinman I; Prendergast P; Remington G; Schertzer S
J Nerv Ment Dis; 1994 Jun; 182(6):360-2. PubMed ID: 7911156
[No Abstract] [Full Text] [Related]
15. Problems of informed consent for clinical trials in psychiatry.
Helmchen H
Control Clin Trials; 1981 May; 1(4):435-40. PubMed ID: 7261635
[TBL] [Abstract][Full Text] [Related]
16. Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?
Roth LH
J Clin Psychopharmacol; 1983 Jun; 3(3):207-8. PubMed ID: 6135724
[No Abstract] [Full Text] [Related]
17. Patients as research participants.
Eth S
Am J Psychiatry; 1981 Nov; 138(11):1518-9. PubMed ID: 7294235
[No Abstract] [Full Text] [Related]
18. Tardive dyskinesia: legal issues and consent.
Gupta S; Frank B; Madhusoodanan S
Psychiatr Ann; 2002 Apr; 32(4):245-8. PubMed ID: 12774783
[No Abstract] [Full Text] [Related]
19. The therapeutic misconception: informed consent in psychiatric research.
Appelbaum PS; Roth LH; Lidz C
Int J Law Psychiatry; 1982; 5(3-4):319-29. PubMed ID: 6135666
[No Abstract] [Full Text] [Related]
20. Documenting informed consent for treatment with neuroleptics: an alternative to the consent form.
Munetz MR; Peterson GA
Psychiatr Serv; 1996 Mar; 47(3):302-3. PubMed ID: 8820557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
